Prognostic indicators of renal disease progression in adults with fabry disease

Natural history data from the Fabry Registry

Christoph Wanner, João P. Oliveira, Alberto Ortiz, Michael Mauer, Dominique P. Germain, Gabor E. Linthorst, Andreas L. Serra, L. Máródi, Renzo Mignani, Bruno Cianciaruso, Bojan Vujkovac, Roberta Lemay, Dana Beitner-Johnson, Stephen Waldek, David G. Warnock

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Background and objectives: These analyses were designed to characterize renal disease progression in untreated adults with Fabry disease. Design, setting, participants, & measurements: Data from the Fabry Registry for 462 untreated adults (121 men and 341 women) who had at least two estimated GFR (eGFR) values over a span of ≥12 months before starting enzyme replacement therapy were included. Results: Most men (86 of 121, 71%) had more rapid loss of kidney function than the normal adult population (loss of eGFR > -1 ml/min per 1.73 m2 per year), whereas fewer women (133 of 341, 39%) had rapid loss of kidney function. Patients with rapid progression had significantly higher mean averaged urinary protein to urinary creatinine ratios (UP/Cr) than patients with slower progression (1.5 versus 0.2 for men; 1.4 versus 0.5 for women; P <0.0001). Patients were grouped into quartiles based on averaged UP/Cr; renal function in men declined more rapidly with higher UP/Cr, with the steepest declines observed in men with UP/Cr > 1.5 (mean eGFR slope, -5.6 ml/min per 1.73 m2 per year; n = 30). eGFR slope declined more slowly in women, with the steepest declines observed in women with UP/Cr > 1.2 (mean eGFR slope, -1.3 ml/min per 1.73 m2 per year; n = 85). Regression models of eGFR slope indicated that UP/Cr is the most important indicator of renal disease progression in adult Fabry patients. In women, lower baseline eGFR and age were also associated with renal disease progression. Women who had clinical events had more rapid loss of kidney function. Conclusions: Urinary protein excretion is strongly associated with renal disease progression in men and women with Fabry disease.

Original languageEnglish
Pages (from-to)2220-2228
Number of pages9
JournalClinical Journal of the American Society of Nephrology
Volume5
Issue number12
DOIs
Publication statusPublished - Dec 1 2010

Fingerprint

Fabry Disease
Natural History
Registries
Disease Progression
Kidney
Creatinine
Proteins
Enzyme Replacement Therapy

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Prognostic indicators of renal disease progression in adults with fabry disease : Natural history data from the Fabry Registry. / Wanner, Christoph; Oliveira, João P.; Ortiz, Alberto; Mauer, Michael; Germain, Dominique P.; Linthorst, Gabor E.; Serra, Andreas L.; Máródi, L.; Mignani, Renzo; Cianciaruso, Bruno; Vujkovac, Bojan; Lemay, Roberta; Beitner-Johnson, Dana; Waldek, Stephen; Warnock, David G.

In: Clinical Journal of the American Society of Nephrology, Vol. 5, No. 12, 01.12.2010, p. 2220-2228.

Research output: Contribution to journalArticle

Wanner, C, Oliveira, JP, Ortiz, A, Mauer, M, Germain, DP, Linthorst, GE, Serra, AL, Máródi, L, Mignani, R, Cianciaruso, B, Vujkovac, B, Lemay, R, Beitner-Johnson, D, Waldek, S & Warnock, DG 2010, 'Prognostic indicators of renal disease progression in adults with fabry disease: Natural history data from the Fabry Registry', Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2220-2228. https://doi.org/10.2215/CJN.04340510
Wanner, Christoph ; Oliveira, João P. ; Ortiz, Alberto ; Mauer, Michael ; Germain, Dominique P. ; Linthorst, Gabor E. ; Serra, Andreas L. ; Máródi, L. ; Mignani, Renzo ; Cianciaruso, Bruno ; Vujkovac, Bojan ; Lemay, Roberta ; Beitner-Johnson, Dana ; Waldek, Stephen ; Warnock, David G. / Prognostic indicators of renal disease progression in adults with fabry disease : Natural history data from the Fabry Registry. In: Clinical Journal of the American Society of Nephrology. 2010 ; Vol. 5, No. 12. pp. 2220-2228.
@article{94e86fa7caa44a208fa880e0b385e486,
title = "Prognostic indicators of renal disease progression in adults with fabry disease: Natural history data from the Fabry Registry",
abstract = "Background and objectives: These analyses were designed to characterize renal disease progression in untreated adults with Fabry disease. Design, setting, participants, & measurements: Data from the Fabry Registry for 462 untreated adults (121 men and 341 women) who had at least two estimated GFR (eGFR) values over a span of ≥12 months before starting enzyme replacement therapy were included. Results: Most men (86 of 121, 71{\%}) had more rapid loss of kidney function than the normal adult population (loss of eGFR > -1 ml/min per 1.73 m2 per year), whereas fewer women (133 of 341, 39{\%}) had rapid loss of kidney function. Patients with rapid progression had significantly higher mean averaged urinary protein to urinary creatinine ratios (UP/Cr) than patients with slower progression (1.5 versus 0.2 for men; 1.4 versus 0.5 for women; P <0.0001). Patients were grouped into quartiles based on averaged UP/Cr; renal function in men declined more rapidly with higher UP/Cr, with the steepest declines observed in men with UP/Cr > 1.5 (mean eGFR slope, -5.6 ml/min per 1.73 m2 per year; n = 30). eGFR slope declined more slowly in women, with the steepest declines observed in women with UP/Cr > 1.2 (mean eGFR slope, -1.3 ml/min per 1.73 m2 per year; n = 85). Regression models of eGFR slope indicated that UP/Cr is the most important indicator of renal disease progression in adult Fabry patients. In women, lower baseline eGFR and age were also associated with renal disease progression. Women who had clinical events had more rapid loss of kidney function. Conclusions: Urinary protein excretion is strongly associated with renal disease progression in men and women with Fabry disease.",
author = "Christoph Wanner and Oliveira, {Jo{\~a}o P.} and Alberto Ortiz and Michael Mauer and Germain, {Dominique P.} and Linthorst, {Gabor E.} and Serra, {Andreas L.} and L. M{\'a}r{\'o}di and Renzo Mignani and Bruno Cianciaruso and Bojan Vujkovac and Roberta Lemay and Dana Beitner-Johnson and Stephen Waldek and Warnock, {David G.}",
year = "2010",
month = "12",
day = "1",
doi = "10.2215/CJN.04340510",
language = "English",
volume = "5",
pages = "2220--2228",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "12",

}

TY - JOUR

T1 - Prognostic indicators of renal disease progression in adults with fabry disease

T2 - Natural history data from the Fabry Registry

AU - Wanner, Christoph

AU - Oliveira, João P.

AU - Ortiz, Alberto

AU - Mauer, Michael

AU - Germain, Dominique P.

AU - Linthorst, Gabor E.

AU - Serra, Andreas L.

AU - Máródi, L.

AU - Mignani, Renzo

AU - Cianciaruso, Bruno

AU - Vujkovac, Bojan

AU - Lemay, Roberta

AU - Beitner-Johnson, Dana

AU - Waldek, Stephen

AU - Warnock, David G.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Background and objectives: These analyses were designed to characterize renal disease progression in untreated adults with Fabry disease. Design, setting, participants, & measurements: Data from the Fabry Registry for 462 untreated adults (121 men and 341 women) who had at least two estimated GFR (eGFR) values over a span of ≥12 months before starting enzyme replacement therapy were included. Results: Most men (86 of 121, 71%) had more rapid loss of kidney function than the normal adult population (loss of eGFR > -1 ml/min per 1.73 m2 per year), whereas fewer women (133 of 341, 39%) had rapid loss of kidney function. Patients with rapid progression had significantly higher mean averaged urinary protein to urinary creatinine ratios (UP/Cr) than patients with slower progression (1.5 versus 0.2 for men; 1.4 versus 0.5 for women; P <0.0001). Patients were grouped into quartiles based on averaged UP/Cr; renal function in men declined more rapidly with higher UP/Cr, with the steepest declines observed in men with UP/Cr > 1.5 (mean eGFR slope, -5.6 ml/min per 1.73 m2 per year; n = 30). eGFR slope declined more slowly in women, with the steepest declines observed in women with UP/Cr > 1.2 (mean eGFR slope, -1.3 ml/min per 1.73 m2 per year; n = 85). Regression models of eGFR slope indicated that UP/Cr is the most important indicator of renal disease progression in adult Fabry patients. In women, lower baseline eGFR and age were also associated with renal disease progression. Women who had clinical events had more rapid loss of kidney function. Conclusions: Urinary protein excretion is strongly associated with renal disease progression in men and women with Fabry disease.

AB - Background and objectives: These analyses were designed to characterize renal disease progression in untreated adults with Fabry disease. Design, setting, participants, & measurements: Data from the Fabry Registry for 462 untreated adults (121 men and 341 women) who had at least two estimated GFR (eGFR) values over a span of ≥12 months before starting enzyme replacement therapy were included. Results: Most men (86 of 121, 71%) had more rapid loss of kidney function than the normal adult population (loss of eGFR > -1 ml/min per 1.73 m2 per year), whereas fewer women (133 of 341, 39%) had rapid loss of kidney function. Patients with rapid progression had significantly higher mean averaged urinary protein to urinary creatinine ratios (UP/Cr) than patients with slower progression (1.5 versus 0.2 for men; 1.4 versus 0.5 for women; P <0.0001). Patients were grouped into quartiles based on averaged UP/Cr; renal function in men declined more rapidly with higher UP/Cr, with the steepest declines observed in men with UP/Cr > 1.5 (mean eGFR slope, -5.6 ml/min per 1.73 m2 per year; n = 30). eGFR slope declined more slowly in women, with the steepest declines observed in women with UP/Cr > 1.2 (mean eGFR slope, -1.3 ml/min per 1.73 m2 per year; n = 85). Regression models of eGFR slope indicated that UP/Cr is the most important indicator of renal disease progression in adult Fabry patients. In women, lower baseline eGFR and age were also associated with renal disease progression. Women who had clinical events had more rapid loss of kidney function. Conclusions: Urinary protein excretion is strongly associated with renal disease progression in men and women with Fabry disease.

UR - http://www.scopus.com/inward/record.url?scp=78650371014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650371014&partnerID=8YFLogxK

U2 - 10.2215/CJN.04340510

DO - 10.2215/CJN.04340510

M3 - Article

VL - 5

SP - 2220

EP - 2228

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 12

ER -